azacitidine,tisagenlecleucel
novartis
['elevate,(-elevate uc),(-elevateuc),(-elevate-uc),(-elevate rr),(-elevaterr),(-elevate-rr),(-elevate tn),(-elevatetn),(-elevate-tn)', 'bendamustine', 'tisa-cel', 'arca, (-arcade)']
#ash22
abstract 656 real world data of tisa-cel for r/r lbcl, registry cr and normal ldh prior to infusion are associated with improved efficacy and/or safety outcomes supports the use of debulking and/or bridging therapy to disease burden prior to infusion 
Hematologist at Saint Antoine Hospital, Paris, France @Sorbonne_Univ_ @APHP. @JACIE_EBMT National Representative. #BMTsm #LYMsm #CARTcell #CardioOnc #QoL